← Leaderboards
Jada M Lewis
Mayo Clinic Coll Of Med, Jacksonville
$8,224,231
Attributed
$16,956,479
Total exposure
13
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,956,479 · 13
By mechanism
RF1$6,447,047 · 2
R01$3,915,824 · 3
R21$2,042,750 · 5
R33$1,817,356 · 1
T32$1,533,132 · 1
R61$1,200,370 · 1
Top collaborators
- David R Borchelt15 shared
- Jennifer Lynn Bizon7 shared
- Todd E. Golde3 shared
- Jose Francisco Abisambra2 shared
- Paramita Chakrabarty2 shared
- Ronald J Mandel2 shared
- Karen N Mcfarland1 shared
Most similar at Mayo Clinic Coll Of Med, Jacksonville
Same institution · by research overlap
- Shu-Hui C Yen$4,641,000
- Matthew J Farrer$8,740,276
- Todd E. Golde$22,621,576
- Andrew B West$12,449,699
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposPathologyTau ProteinsBrainMutantTauopathiesNeurofibrillary TanglesS DiseaseMouse ModelProteinsBaseLinkTau MutationTransgenic MicePathway InteractionsGenesCorticobasal DegenerationPathologicInsightFrontotemporal DementiaAmyloidMutationIn VivoAutopsy
Grant awards (35)
Clinical and Translational Predoctoral training in Alzheimers Disease and Related Dementias$308,334
T32 · FY2025 · AG · contact PI
Clinical and Translational Predoctoral training in Alzheimers Disease and Related Dementias$316,680
T32 · FY2024 · AG · contact PI
Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias$77,698
T32 · FY2022 · AG · contact PI
Developing new conditional models to study tauopathy, amyloidosis, and their interaction$1,817,356
R33 · FY2021 · NS · contact PI
Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias$178,288
T32 · FY2021 · AG · contact PI
Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias$176,058
T32 · FY2020 · AG · contact PI
Immunotherapy targeting the HPA axis in Alzheimerâs disease$2,689,784
RF1 · FY2019 · AG
Elucidating factors that modulate tauopathy and cellular degeneration to guide therapeutic development$2,473,595
RF1 · FY2019 · AG · contact PI
Immunotherapy targeting the HPA axis in Alzheimer's disease$1,283,668
RF1 · FY2019 · AG
Developing new conditional models to study tauopathy, amyloidosis, and their interaction$1,200,370
R61 · FY2019 · NS · contact PI
Proteostasis and secondary proteinopathy in AD and FTD$307,500
R01 · FY2019 · AG
Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias$173,881
T32 · FY2019 · AG · contact PI
Proteostasis and secondary proteinopathy in AD and FTD$307,500
R01 · FY2018 · AG
Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias$302,193
T32 · FY2018 · AG · contact PI
Is there a form of benign brain amyloidosis in aging?$228,750
R21 · FY2018 · AG
Biological and Pathological Interactions between Tau and LRRK2$317,745
R01 · FY2017 · NS · contact PI
Proteostasis and secondary proteinopathy in AD and FTD$307,500
R01 · FY2017 · AG
Is there a form of benign brain amyloidosis in aging?$190,625
R21 · FY2017 · AG
Biological and Pathological Interactions between Tau and LRRK2$319,064
R01 · FY2016 · NS · contact PI
Proteostasis and secondary proteinopathy in AD and FTD$307,500
R01 · FY2016 · AG
Biological and Pathological Interactions between Tau and LRRK2$320,276
R01 · FY2015 · NS · contact PI
Proteostasis and secondary proteinopathy in AD and FTD$307,500
R01 · FY2015 · AG
Seeded models of AD pathology$181,875
R21 · FY2015 · AG
Biological and Pathological Interactions between Tau and LRRK2$318,081
R01 · FY2014 · NS · contact PI
Seeded models of AD pathology$224,750
R21 · FY2014 · AG
Proteostasis in Neurodegenerative Disease$187,500
R21 · FY2014 · NS
Biological and Pathological Interactions between Tau and LRRK2$320,119
R01 · FY2013 · NS · contact PI
Proteostasis in Neurodegenerative Disease$223,500
R21 · FY2013 · NS
New Models to Assay Gene Silencing Therapies$183,125
R21 · FY2012 · NS
New Models to Assay Gene Silencing Therapies$219,750
R21 · FY2011 · NS
In vivo modeling of TDP-43 toxicity$183,125
R21 · FY2011 · NS · contact PI
In vivo modeling of TDP-43 toxicity$219,750
R21 · FY2010 · NS · contact PI
A conditional model of Neurofibrillary Pathology$261,013
R01 · FY2005 · NS
A conditional model of Neurofibrillary Pathology$261,013
R01 · FY2004 · NS
A conditional model of Neurofibrillary Pathology$261,013
R01 · FY2003 · NS